Long Thoracic Nerve Blockade for Pain Treatment After Video-Assisted Thoracoscopic Surgery

Not Applicable

• Conditions: Video-Assisted Thoracic Surgery; Nerve Block
• Interventions: Drug: Morphine Sulfate; Drug: Bupivacaine

• Registration Number: NCT03483415
• Lead Sponsor: Bursa Yüksek İhtisas Education and Research Hospital

Brief Summary

Video-assisted thoracoscopic surgery (VATS) provides an opportunity to penetrate the thoracic cavity by video through an incision into the chest wall and facilitate surgical operation of lung pathologies.Various regional methods of anesthesia are currently being used to achieve this goal.

The aim of the study was to assess the effectiveness of Long thoracic nerve bloc on postoperative VATS analgesia.

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-03
• Study First Submitted: 2018-03-19
• Study First Submitted QC: 2018-03-23
• Last Update Submitted: 2018-03-23
• Study First Posted: 2018-03-30
• Last Update Posted: 2018-03-30
• Study Start: 2018-05-01
• Primary Completion: 2019-04-01
• Study Completion: 2019-04-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients who were in the American Society of Anesthesiologists (ASA) I-III class and underwent video-assisted thoracoscopic surgery (VATS).

Exclusion Criteria

• Previous history of opioid use preoperatively,
• Allergy to local anesthetics,
• The presence of any systemic infection,
• Uncontrolled arterial hypertension,
• Uncontrolled diabetes mellitus.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Grup L	Morphine Sulfate	IV patient-controlled analgesia (PCA) morphine + Ultrasound guided Long thoracic nerve blockage with 5 ml % 0.25 bupivacaine
Grup L	Bupivacaine	IV patient-controlled analgesia (PCA) morphine + Ultrasound guided Long thoracic nerve blockage with 5 ml % 0.25 bupivacaine
Group P	Morphine Sulfate	IV patient-controlled analgesia (PCA) morphine

Primary Outcome Measures

Name	Time	Method
morphine consumption	Postoperative 24 hours	morphine consumption

Secondary Outcome Measures

Name	Time	Method
Visual Analog Scale	Postoperative 24 hours	Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)
side effect (Hypotension)	Postoperative 24 hours	side effect Hypotension
additional analgesic use	Postoperative 24 hours	additional analgesic use
side effect (Nausea and vomiting)	Postoperative 24 hours	Nausea and vomiting scale; 1. Nausea and vomiting scale (nausea-vomiting scale (NVS): 1. No nausea is present, 2. Mild nausea is present. 3. Severe nausea is present. 4. Vomiting is present) In case of a NVS score of \>3, an anti-emetic drug was administered.
side effect (Ramsay Sedation Scale (RSS)	Postoperative 24 hours	Ramsay Sedation Scale (Ramsay Sedation Scale (RSS) : 1. Anxiety, agitation are present; 2. Cooperated, awake; 3. Sedatized, response to commands; 4. Sleepy, immediately awoken by auditory stimulus or glabella tap; 5. Sleepy, deep response to auditory stimulus or glabella tap and 6. Sleepy, no response to auditory stimulus or glabella tap)